 | • レポートコード：MRC2-11QY14202 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカリウムチャネル遮断薬のグローバル市場について調査・分析したレポートです。種類別（臨床、非臨床、非アクティブ）市場規模、用途別（クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カリウムチャネル遮断薬の競争状況、市場シェア ・世界のカリウムチャネル遮断薬市場：種類別市場規模 2015年-2020年（臨床、非臨床、非アクティブ） ・世界のカリウムチャネル遮断薬市場：種類別市場規模予測 2021年-2026年（臨床、非臨床、非アクティブ） ・世界のカリウムチャネル遮断薬市場：用途別市場規模 2015年-2020年（クリニック、病院） ・世界のカリウムチャネル遮断薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院） ・北米のカリウムチャネル遮断薬市場分析：米国、カナダ ・ヨーロッパのカリウムチャネル遮断薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカリウムチャネル遮断薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカリウムチャネル遮断薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカリウムチャネル遮断薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Kineta、Sevion Therapeutics、Cono Genetix、KPI Therapeutics、Amgen、Agenus bio、Bristol-Myers Squibb、Enumeral、F-star、GlaxoSmithKline、North Coast Bio、Novartis、Regeneron ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Potassium Channel Blockers is a class of drugs that act by inhibition of potassium efflux through cell membranes.
Market Analysis and Insights: Global Potassium Channel Blocker Market
The global Potassium Channel Blocker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Potassium Channel Blocker Scope and Market Size
Potassium Channel Blocker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Potassium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Potassium Channel Blocker market is segmented into
Clinical
Non-clinical
Inactive
Segment by Application, the Potassium Channel Blocker market is segmented into
Clinic
Hospital
Regional and Country-level Analysis
The Potassium Channel Blocker market is analysed and market size information is provided by regions (countries).
The key regions covered in the Potassium Channel Blocker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Potassium Channel Blocker Market Share Analysis
Potassium Channel Blocker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Potassium Channel Blocker business, the date to enter into the Potassium Channel Blocker market, Potassium Channel Blocker product introduction, recent developments, etc.
The major vendors covered:
Kineta
Sevion Therapeutics
Cono Genetix
KPI Therapeutics
Amgen
Agenus bio
Bristol-Myers Squibb
Enumeral
F-star
GlaxoSmithKline
North Coast Bio
Novartis
Regeneron
1 Study Coverage
1.1 Potassium Channel Blocker Product Introduction
1.2 Market Segments
1.3 Key Potassium Channel Blocker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Potassium Channel Blocker Market Size Growth Rate by Type
1.4.2 Clinical
1.4.3 Non-clinical
1.4.4 Inactive
1.5 Market by Application
1.5.1 Global Potassium Channel Blocker Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Potassium Channel Blocker Market Size, Estimates and Forecasts
2.1.1 Global Potassium Channel Blocker Revenue 2015-2026
2.1.2 Global Potassium Channel Blocker Sales 2015-2026
2.2 Global Potassium Channel Blocker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Potassium Channel Blocker Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Potassium Channel Blocker Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Potassium Channel Blocker Competitor Landscape by Players
3.1 Potassium Channel Blocker Sales by Manufacturers
3.1.1 Potassium Channel Blocker Sales by Manufacturers (2015-2020)
3.1.2 Potassium Channel Blocker Sales Market Share by Manufacturers (2015-2020)
3.2 Potassium Channel Blocker Revenue by Manufacturers
3.2.1 Potassium Channel Blocker Revenue by Manufacturers (2015-2020)
3.2.2 Potassium Channel Blocker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Potassium Channel Blocker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Potassium Channel Blocker Revenue in 2019
3.2.5 Global Potassium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Potassium Channel Blocker Price by Manufacturers
3.4 Potassium Channel Blocker Manufacturing Base Distribution, Product Types
3.4.1 Potassium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Potassium Channel Blocker Product Type
3.4.3 Date of International Manufacturers Enter into Potassium Channel Blocker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Potassium Channel Blocker Market Size by Type (2015-2020)
4.1.1 Global Potassium Channel Blocker Sales by Type (2015-2020)
4.1.2 Global Potassium Channel Blocker Revenue by Type (2015-2020)
4.1.3 Potassium Channel Blocker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Potassium Channel Blocker Market Size Forecast by Type (2021-2026)
4.2.1 Global Potassium Channel Blocker Sales Forecast by Type (2021-2026)
4.2.2 Global Potassium Channel Blocker Revenue Forecast by Type (2021-2026)
4.2.3 Potassium Channel Blocker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Potassium Channel Blocker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Potassium Channel Blocker Market Size by Application (2015-2020)
5.1.1 Global Potassium Channel Blocker Sales by Application (2015-2020)
5.1.2 Global Potassium Channel Blocker Revenue by Application (2015-2020)
5.1.3 Potassium Channel Blocker Price by Application (2015-2020)
5.2 Potassium Channel Blocker Market Size Forecast by Application (2021-2026)
5.2.1 Global Potassium Channel Blocker Sales Forecast by Application (2021-2026)
5.2.2 Global Potassium Channel Blocker Revenue Forecast by Application (2021-2026)
5.2.3 Global Potassium Channel Blocker Price Forecast by Application (2021-2026)
6 North America
6.1 North America Potassium Channel Blocker by Country
6.1.1 North America Potassium Channel Blocker Sales by Country
6.1.2 North America Potassium Channel Blocker Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Potassium Channel Blocker Market Facts & Figures by Type
6.3 North America Potassium Channel Blocker Market Facts & Figures by Application
7 Europe
7.1 Europe Potassium Channel Blocker by Country
7.1.1 Europe Potassium Channel Blocker Sales by Country
7.1.2 Europe Potassium Channel Blocker Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Potassium Channel Blocker Market Facts & Figures by Type
7.3 Europe Potassium Channel Blocker Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Potassium Channel Blocker by Region
8.1.1 Asia Pacific Potassium Channel Blocker Sales by Region
8.1.2 Asia Pacific Potassium Channel Blocker Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Potassium Channel Blocker Market Facts & Figures by Type
8.3 Asia Pacific Potassium Channel Blocker Market Facts & Figures by Application
9 Latin America
9.1 Latin America Potassium Channel Blocker by Country
9.1.1 Latin America Potassium Channel Blocker Sales by Country
9.1.2 Latin America Potassium Channel Blocker Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Potassium Channel Blocker Market Facts & Figures by Type
9.3 Central & South America Potassium Channel Blocker Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Potassium Channel Blocker by Country
10.1.1 Middle East and Africa Potassium Channel Blocker Sales by Country
10.1.2 Middle East and Africa Potassium Channel Blocker Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Potassium Channel Blocker Market Facts & Figures by Type
10.3 Middle East and Africa Potassium Channel Blocker Market Facts & Figures by Application
11 Company Profiles
11.1 Kineta
11.1.1 Kineta Corporation Information
11.1.2 Kineta Description and Business Overview
11.1.3 Kineta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Kineta Potassium Channel Blocker Products Offered
11.1.5 Kineta Related Developments
11.2 Sevion Therapeutics
11.2.1 Sevion Therapeutics Corporation Information
11.2.2 Sevion Therapeutics Description and Business Overview
11.2.3 Sevion Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sevion Therapeutics Potassium Channel Blocker Products Offered
11.2.5 Sevion Therapeutics Related Developments
11.3 Cono Genetix
11.3.1 Cono Genetix Corporation Information
11.3.2 Cono Genetix Description and Business Overview
11.3.3 Cono Genetix Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cono Genetix Potassium Channel Blocker Products Offered
11.3.5 Cono Genetix Related Developments
11.4 KPI Therapeutics
11.4.1 KPI Therapeutics Corporation Information
11.4.2 KPI Therapeutics Description and Business Overview
11.4.3 KPI Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 KPI Therapeutics Potassium Channel Blocker Products Offered
11.4.5 KPI Therapeutics Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Potassium Channel Blocker Products Offered
11.5.5 Amgen Related Developments
11.6 Agenus bio
11.6.1 Agenus bio Corporation Information
11.6.2 Agenus bio Description and Business Overview
11.6.3 Agenus bio Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Agenus bio Potassium Channel Blocker Products Offered
11.6.5 Agenus bio Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Potassium Channel Blocker Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.8 Enumeral
11.8.1 Enumeral Corporation Information
11.8.2 Enumeral Description and Business Overview
11.8.3 Enumeral Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Enumeral Potassium Channel Blocker Products Offered
11.8.5 Enumeral Related Developments
11.9 F-star
11.9.1 F-star Corporation Information
11.9.2 F-star Description and Business Overview
11.9.3 F-star Sales, Revenue and Gross Margin (2015-2020)
11.9.4 F-star Potassium Channel Blocker Products Offered
11.9.5 F-star Related Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description and Business Overview
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Potassium Channel Blocker Products Offered
11.10.5 GlaxoSmithKline Related Developments
11.1 Kineta
11.1.1 Kineta Corporation Information
11.1.2 Kineta Description and Business Overview
11.1.3 Kineta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Kineta Potassium Channel Blocker Products Offered
11.1.5 Kineta Related Developments
11.12 Novartis
11.12.1 Novartis Corporation Information
11.12.2 Novartis Description and Business Overview
11.12.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Novartis Products Offered
11.12.5 Novartis Related Developments
11.13 Regeneron
11.13.1 Regeneron Corporation Information
11.13.2 Regeneron Description and Business Overview
11.13.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Regeneron Products Offered
11.13.5 Regeneron Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Potassium Channel Blocker Market Estimates and Projections by Region
12.1.1 Global Potassium Channel Blocker Sales Forecast by Regions 2021-2026
12.1.2 Global Potassium Channel Blocker Revenue Forecast by Regions 2021-2026
12.2 North America Potassium Channel Blocker Market Size Forecast (2021-2026)
12.2.1 North America: Potassium Channel Blocker Sales Forecast (2021-2026)
12.2.2 North America: Potassium Channel Blocker Revenue Forecast (2021-2026)
12.2.3 North America: Potassium Channel Blocker Market Size Forecast by Country (2021-2026)
12.3 Europe Potassium Channel Blocker Market Size Forecast (2021-2026)
12.3.1 Europe: Potassium Channel Blocker Sales Forecast (2021-2026)
12.3.2 Europe: Potassium Channel Blocker Revenue Forecast (2021-2026)
12.3.3 Europe: Potassium Channel Blocker Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Potassium Channel Blocker Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Potassium Channel Blocker Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Potassium Channel Blocker Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Potassium Channel Blocker Market Size Forecast by Region (2021-2026)
12.5 Latin America Potassium Channel Blocker Market Size Forecast (2021-2026)
12.5.1 Latin America: Potassium Channel Blocker Sales Forecast (2021-2026)
12.5.2 Latin America: Potassium Channel Blocker Revenue Forecast (2021-2026)
12.5.3 Latin America: Potassium Channel Blocker Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Potassium Channel Blocker Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Potassium Channel Blocker Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Potassium Channel Blocker Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Potassium Channel Blocker Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Potassium Channel Blocker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Potassium Channel Blocker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Potassium Channel Blocker Market Segments
Table 2. Ranking of Global Top Potassium Channel Blocker Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Potassium Channel Blocker Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Clinical
Table 5. Major Manufacturers of Non-clinical
Table 6. Major Manufacturers of Inactive
Table 7. Global Potassium Channel Blocker Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Potassium Channel Blocker Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Potassium Channel Blocker Sales by Regions 2015-2020 (K MT)
Table 10. Global Potassium Channel Blocker Sales Market Share by Regions (2015-2020)
Table 11. Global Potassium Channel Blocker Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Potassium Channel Blocker Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Potassium Channel Blocker Sales Share by Manufacturers (2015-2020)
Table 14. Global Potassium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Potassium Channel Blocker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Potassium Channel Blocker as of 2019)
Table 16. Potassium Channel Blocker Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Potassium Channel Blocker Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Potassium Channel Blocker Price (2015-2020) (USD/MT)
Table 19. Potassium Channel Blocker Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Potassium Channel Blocker Product Type
Table 21. Date of International Manufacturers Enter into Potassium Channel Blocker Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 24. Global Potassium Channel Blocker Sales Share by Type (2015-2020)
Table 25. Global Potassium Channel Blocker Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Potassium Channel Blocker Revenue Share by Type (2015-2020)
Table 27. Potassium Channel Blocker Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 29. Global Potassium Channel Blocker Sales Share by Application (2015-2020)
Table 30. North America Potassium Channel Blocker Sales by Country (2015-2020) (K MT)
Table 31. North America Potassium Channel Blocker Sales Market Share by Country (2015-2020)
Table 32. North America Potassium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Potassium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 34. North America Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 35. North America Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Table 36. North America Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 37. North America Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Table 38. Europe Potassium Channel Blocker Sales by Country (2015-2020) (K MT)
Table 39. Europe Potassium Channel Blocker Sales Market Share by Country (2015-2020)
Table 40. Europe Potassium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Potassium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 42. Europe Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 43. Europe Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Table 44. Europe Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 45. Europe Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Potassium Channel Blocker Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Potassium Channel Blocker Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Potassium Channel Blocker Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Potassium Channel Blocker Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Table 54. Latin America Potassium Channel Blocker Sales by Country (2015-2020) (K MT)
Table 55. Latin America Potassium Channel Blocker Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Potassium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Potassium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 58. Latin America Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 59. Latin America Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Table 60. Latin America Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 61. Latin America Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Potassium Channel Blocker Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Potassium Channel Blocker Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Potassium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Potassium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Potassium Channel Blocker Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Potassium Channel Blocker Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Table 70. Kineta Corporation Information
Table 71. Kineta Description and Major Businesses
Table 72. Kineta Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Kineta Product
Table 74. Kineta Recent Development
Table 75. Sevion Therapeutics Corporation Information
Table 76. Sevion Therapeutics Description and Major Businesses
Table 77. Sevion Therapeutics Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Sevion Therapeutics Product
Table 79. Sevion Therapeutics Recent Development
Table 80. Cono Genetix Corporation Information
Table 81. Cono Genetix Description and Major Businesses
Table 82. Cono Genetix Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cono Genetix Product
Table 84. Cono Genetix Recent Development
Table 85. KPI Therapeutics Corporation Information
Table 86. KPI Therapeutics Description and Major Businesses
Table 87. KPI Therapeutics Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. KPI Therapeutics Product
Table 89. KPI Therapeutics Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Major Businesses
Table 92. Amgen Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Product
Table 94. Amgen Recent Development
Table 95. Agenus bio Corporation Information
Table 96. Agenus bio Description and Major Businesses
Table 97. Agenus bio Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Agenus bio Product
Table 99. Agenus bio Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Major Businesses
Table 102. Bristol-Myers Squibb Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Enumeral Corporation Information
Table 106. Enumeral Description and Major Businesses
Table 107. Enumeral Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Enumeral Product
Table 109. Enumeral Recent Development
Table 110. F-star Corporation Information
Table 111. F-star Description and Major Businesses
Table 112. F-star Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. F-star Product
Table 114. F-star Recent Development
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Major Businesses
Table 117. GlaxoSmithKline Potassium Channel Blocker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. GlaxoSmithKline Product
Table 119. GlaxoSmithKline Recent Development
Table 120. North Coast Bio Corporation Information
Table 121. North Coast Bio Description and Major Businesses
Table 122. North Coast Bio Potassium Channel Blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. North Coast Bio Product
Table 124. North Coast Bio Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Potassium Channel Blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Novartis Product
Table 129. Novartis Recent Development
Table 130. Regeneron Corporation Information
Table 131. Regeneron Description and Major Businesses
Table 132. Regeneron Potassium Channel Blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Regeneron Product
Table 134. Regeneron Recent Development
Table 135. Global Potassium Channel Blocker Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Potassium Channel Blocker Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Potassium Channel Blocker Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Potassium Channel Blocker Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Potassium Channel Blocker Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Potassium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Potassium Channel Blocker Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Potassium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Potassium Channel Blocker Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Potassium Channel Blocker Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Potassium Channel Blocker Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Potassium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Potassium Channel Blocker Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Potassium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Potassium Channel Blocker Players
Table 153. Potassium Channel Blocker Customers List
Table 154. Potassium Channel Blocker Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Potassium Channel Blocker Product Picture
Figure 2. Global Potassium Channel Blocker Sales Market Share by Type in 2020 & 2026
Figure 3. Clinical Product Picture
Figure 4. Non-clinical Product Picture
Figure 5. Inactive Product Picture
Figure 6. Global Potassium Channel Blocker Sales Market Share by Application in 2020 & 2026
Figure 7. Clinic
Figure 8. Hospital
Figure 9. Potassium Channel Blocker Report Years Considered
Figure 10. Global Potassium Channel Blocker Market Size 2015-2026 (US$ Million)
Figure 11. Global Potassium Channel Blocker Sales 2015-2026 (K MT)
Figure 12. Global Potassium Channel Blocker Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Potassium Channel Blocker Sales Market Share by Region (2015-2020)
Figure 14. Global Potassium Channel Blocker Sales Market Share by Region in 2019
Figure 15. Global Potassium Channel Blocker Revenue Market Share by Region (2015-2020)
Figure 16. Global Potassium Channel Blocker Revenue Market Share by Region in 2019
Figure 17. Global Potassium Channel Blocker Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Potassium Channel Blocker Revenue in 2019
Figure 19. Potassium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Potassium Channel Blocker Sales Market Share by Type (2015-2020)
Figure 21. Global Potassium Channel Blocker Sales Market Share by Type in 2019
Figure 22. Global Potassium Channel Blocker Revenue Market Share by Type (2015-2020)
Figure 23. Global Potassium Channel Blocker Revenue Market Share by Type in 2019
Figure 24. Global Potassium Channel Blocker Market Share by Price Range (2015-2020)
Figure 25. Global Potassium Channel Blocker Sales Market Share by Application (2015-2020)
Figure 26. Global Potassium Channel Blocker Sales Market Share by Application in 2019
Figure 27. Global Potassium Channel Blocker Revenue Market Share by Application (2015-2020)
Figure 28. Global Potassium Channel Blocker Revenue Market Share by Application in 2019
Figure 29. North America Potassium Channel Blocker Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Potassium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Potassium Channel Blocker Sales Market Share by Country in 2019
Figure 32. North America Potassium Channel Blocker Revenue Market Share by Country in 2019
Figure 33. U.S. Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Potassium Channel Blocker Market Share by Type in 2019
Figure 38. North America Potassium Channel Blocker Market Share by Application in 2019
Figure 39. Europe Potassium Channel Blocker Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Potassium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Potassium Channel Blocker Sales Market Share by Country in 2019
Figure 42. Europe Potassium Channel Blocker Revenue Market Share by Country in 2019
Figure 43. Germany Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Potassium Channel Blocker Market Share by Type in 2019
Figure 54. Europe Potassium Channel Blocker Market Share by Application in 2019
Figure 55. Asia Pacific Potassium Channel Blocker Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Potassium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Potassium Channel Blocker Sales Market Share by Region in 2019
Figure 58. Asia Pacific Potassium Channel Blocker Revenue Market Share by Region in 2019
Figure 59. China Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Potassium Channel Blocker Market Share by Type in 2019
Figure 82. Asia Pacific Potassium Channel Blocker Market Share by Application in 2019
Figure 83. Latin America Potassium Channel Blocker Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Potassium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Potassium Channel Blocker Sales Market Share by Country in 2019
Figure 86. Latin America Potassium Channel Blocker Revenue Market Share by Country in 2019
Figure 87. Mexico Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Potassium Channel Blocker Market Share by Type in 2019
Figure 94. Latin America Potassium Channel Blocker Market Share by Application in 2019
Figure 95. Middle East and Africa Potassium Channel Blocker Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Potassium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Potassium Channel Blocker Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Potassium Channel Blocker Revenue Market Share by Country in 2019
Figure 99. Turkey Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Potassium Channel Blocker Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Potassium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Potassium Channel Blocker Market Share by Type in 2019
Figure 106. Middle East and Africa Potassium Channel Blocker Market Share by Application in 2019
Figure 107. North America Potassium Channel Blocker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Potassium Channel Blocker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Potassium Channel Blocker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Potassium Channel Blocker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Potassium Channel Blocker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Potassium Channel Blocker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Potassium Channel Blocker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Potassium Channel Blocker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Potassium Channel Blocker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Potassium Channel Blocker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
塩化物チャネル遮断薬の世界市場（～2026年） A chloride channel blocker is a type of drug which inhibits the transmission of ions (Cl−) through chloride channels. Niflumic acid is a chloride channel blocker that has been used in experimental scientific research. Market Analysis and Insights: Global Chloride Channel Blocker Market The global Ch…- チャンネル・イン・ア・ボックス（CiaB）の世界市場（～2026年） Channel-in-a-box (CiaB) is defined as collapsing the pieces of traditional master control and playout chain such as switchers, graphics, servers, audio, routing and channel branding into a single integrated software application that runs on generic IT-based hardware. The market is driven by its late…
- フルオロアルミン酸カリウムの世界市場（～2026年） Potassium fluoroaluminate is an organic chemical with the formula KalF4. It is manufactured by reacting aluminum hydroxide, hydrogen fluoride, and potassium hydroxide in an aqueous medium under vacuum. Potassium fluoroaluminate is used as an active filler in resin bonded abrasives for metal treatmen…
- カリウムアルミニウムフッ化物の世界市場（～2026年） Potassium aluminium fluoride is an inorganic compound. This compound is used as flux in the smelting of secondary aluminium, to reduce or remove the magnesium content of the melt. The main environmental issue that arises from using PAF is the production of fluoride gases. Market Analysis and Insight…
- 鉄酸カリウムの世界市場（～2026年） Potassium ferrate is usually produced through a wet synthesis or using an electrosynthesis where the equipment is exposed to aggressive conditions. Both methods use high concentration of hydroxides that are usually present in the final solution together with various salts. Moreover, ferrate solution…